News – Page 41 – Endpoints News

J&J seeks to stop Samsung Bioepis from licensing Stelara biosimilar

3 months ago

En vogue Chinese ADC biotech lets Hong Kong IPO filing lapse

3 months ago

Thermo Fisher buys biologics purification business from Solventum for $4.1B

3 months ago

Indian drugmakers join forces to boost national biomanufacturing sector

3 months ago

Lilly pays $10M upfront for Organovo’s FXR agonist program

3 months ago

Repare to lay off 75% of staff; Castle Creek inks $75M royalty deal

3 months ago

Is the GLP-1 compounding boom over? Not exactly

3 months ago

Hims eyes growth in its weight loss business, despite end of semaglutide shortage

3 months ago

Who’s leading LGBTQ+ inclusion in biopharma? Nominate them for Endpoints’ annual report

3 months ago

BridGene nets another Takeda deal amid plans to raise more funding and go public

3 months ago

Where the money is: The top 100 venture investors in biotech

3 months ago

Alnylam eyes bigger diseases in more tissue types at ‘inflection point’ for siRNA

3 months ago

Eli Lilly expands Zepbound single-dose vial options at lower price

3 months ago

Alcon tried to sink Aurion's IPO in 'Valentine's Day massacre,' new lawsuits say

3 months ago

Some FDA medical device staff reinstated just days after receiving pink slips

3 months ago

23andMe's CEO submits bid to take company private for $74.7M

3 months ago

FDA lifts hold on Entrada's Duchenne drug after two years

3 months ago

FDA won’t allow Invivyd’s Pemgarda to treat Covid; Antibiotic biotech launches

3 months ago

Pfizer hires ex-FDA deputy Patrizia Cavazzoni as chief medical officer

3 months ago

Amgen plans further $200M investment in new tech facility in India

3 months ago

Sanofi, Teva bolster case for IBD drug with Phase 2 data, despite potential competition

3 months ago

Pfizer wants in on Summit’s goal to beat Keytruda via ADC combos

3 months ago

Post-Hoc: Pharma CEOs' alternative reality with Trump

3 months ago

Bourla praises Trump as RFK Jr. preps vaccine review; Will CRISPR matter?; Atomwise hires new CEO; and more

3 months ago

First page Previous page 38 39 404142 43 44 Next page Last page